Cluster randomised controlled trial comparing the effectiveness and cost-effectiveness of two primary care interventions aimed at improving attendance for breast screening
Sh. Richards et al., Cluster randomised controlled trial comparing the effectiveness and cost-effectiveness of two primary care interventions aimed at improving attendance for breast screening, J MED SCREE, 8(2), 2001, pp. 91-98
Objectives-To examine the effectiveness and cost-effectiveness of two inter
ventions based in primary care aimed at increasing uptake of breast screeni
ng.
Setting-24 General practices with low uptake in the second round of screeni
ng (below 60%) in north west London and the West Midlands, UK. Participants
were all women registered with these practices and eligible for screening
in the third round.
Methods-Pragmatic factorial cluster randomised controlled trial, with pract
ices randomised to a systematic intervention (general practitioner letter),
an opportunistic intervention (flag in women's notes prompting discussion
by health professionals), neither intervention, or both. Outcome measures w
ere attendance for screening 6 months after the practices had been screened
and cost-effectiveness of the interventions.
Results-6133 Women were included: 1721 control; 1818 letter; 1232 flag; 136
2 both interventions. Attendance data were obtained for 5732 (93%) women. T
he two interventions independently increased breast screening uptake in a l
ogistic regression model adjusted for clustering, with the flag (odds ratio
(OR) 1.43, 95% confidence interval (95% CI) 1.14 to 1.79; p=0.0019) margin
ally more effective than the letter (OR 1.31, 95% CI 1.05 to 1.64; p=0.015)
. Health service costs per additional attendance were pound 26 (letter) and
pound 41 (flag).
Conclusions-Although both interventions increased attendance for breast scr
eening, the letter was the more cost-effective. Any decision to implement b
oth interventions rather than just the letter will depend on whether the ad
ditional (pound 41) costs are judged worthwhile in terms of the gains in br
east screening uptake.